HOP/HSP90 复合物介导转录因子Snail核转位促进胃癌EMT的分子机制
批准号:
81772579
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
何裕隆
依托单位:
学科分类:
H1809.肿瘤复发与转移
结题年份:
2021
批准年份:
2017
项目状态:
已结题
项目参与者:
李广华、陈剑辉、詹晓勇、陈伟、蔡钦波、周志军、余捷、石鹏
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
解决胃癌转移是目前临床工作的难点,阐明其机制极为重要。前期发现HOP在胃癌高表达,下调HOP抑制胃癌EMT并减少转移;质谱分析发现HOP与Snail蛋白结合,Co-IP证实其蛋白互作,并在胃癌EMT时在细胞核协同增高;HOP与Snail结合由HSP90为中介,HSP90在胃癌EMT时入核增多,下调HSP90阻断HOP/Snail结合,而敲除Snail不影响HOP/HSP90结合。基于此提出假设:HOP/HSP90复合物介导Snail核转位促进胃癌EMT。后续用全基因组表达谱芯片检测HOP下游靶基因和信号通路,并进行验证;用Co-IP联合基因差异表达,明确HOP/HSP90介导Snail核转位;用缺失突变联合Co-IP明确HOP/HSP90与HSP90/Snail互作位点;并在体内验证;最后在临床标本分析各基因相关性和临床意义。本项目有助于揭示胃癌EMT机制,并为胃癌临床诊疗策略提供新思路
英文摘要
To solve the metastasis of gastric cancer is difficulty in the present clinical work, and clarifing its mechanisms is very important. In previous study, we found HOP is highly expressed in gastric cancer, knockdown of HOP could inhibit cell epithelial-to-mesenchymal transitions and reduce metastasis in gastric cancer; the mass spectrometry analysis indicated the combination of HOP and Snail, Co-IP assay confirmed the protein interactions in previous experimental, and we found that HOP and Snail positively coordinated expression in cell nuclear during gastric cancer cell EMT; the HSP90 is the scaffold protein that binding HOP and Snail, it could nuclear translocation during cell EMT, and down-regualtion of HSP90 could block the combination of HOP and Snail, while knockdown of Snail did not affect the interaction HOP and HSP90. Thus, we propose the hypothesis that HOP/HSP90 complex mediates nuclear translocation of Snail and promotes EMT in gastric cancer. In this study, the genome-wide expression profile array would be used to detect downstream target genes and signaling pathway of HOP; Co-IP combined with gene gain- or loss- assay were used to demonstrate the hypothesis of HOP/HSP90 complex mediating Snail nuclear translocation; with the functional domain mutation and Co-IP, we would explore the interaction sites of HOP and HSP90 or HSP90 and Snail; we would detect our findings in vivo; finally, the correlation and clinical significance of each gene would be detected in clinical specimens. This study is supposed to reveal the mechanism of EMT in gastric cancer, and provide evidences for clinical diagnosis and treatment strategy of gastric cancer.
本项目证实HSP70/HSP90 组织蛋白 (HOP) 在胃癌组织中的表达水平显着高于正常组织。此外,胃癌患者血清中HOP 的血清水平也更高。胃癌细胞自分泌的HOP通过PLCγ1和ERK1/2抑制细胞凋亡,并且可以增强胃癌细胞化疗抵抗。我们的研究结果表明,HOP 是胃癌重要的分子标志物和预后影响因素,未来有望成为胃癌的治疗新靶点。此外,我们还证明幽门螺杆菌通过CXCR2的介导促进胃黏膜上皮细胞衰老。幽门螺杆菌感染不仅上调了CXCR2,CXCL1,CXCL8,并且直接通过NFKB1直接结合CXCR2的启动子调控其表达。此外,CXCR2 形成了一个与 p53 的正反馈回路促进细胞衰老,阐明了幽门螺杆菌通过促进细胞衰老诱导胃癌发生的新机制。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway
STIP1敲低通过抑制STAT3通路抑制结直肠癌细胞增殖、迁移和侵袭。
DOI:10.1016/j.cbi.2021.109446
发表时间:2021-04-06
期刊:CHEMICO-BIOLOGICAL INTERACTIONS
影响因子:5.1
作者:Xia, YuJian;Chen, Jian;He, YuLong
通讯作者:He, YuLong
HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer
HSP70/HSP90 组织蛋白以自分泌方式促进胃癌进展并预测胃癌的不良生存
DOI:10.1159/000490080
发表时间:2018-01-01
期刊:CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
影响因子:--
作者:Zhai, Ertao;Liang, Wei;Peng, Sui
通讯作者:Peng, Sui
Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients.
表达 LILRB1 且富含 M2 巨噬细胞的胃癌患者预后不良且治疗反应不佳
DOI:10.3389/fonc.2021.668707
发表时间:2021
期刊:Frontiers in oncology
影响因子:4.7
作者:Zhang Y;Wang H;Xu X;Liu H;Hao T;Yin S;Zhang C;He Y
通讯作者:He Y
Inflammation-Associated Senescence Promotes Helicobacter pylori-Induced Atrophic Gastritis.
炎症相关的衰老促进幽门螺杆菌诱发的萎缩性胃炎
DOI:10.1016/j.jcmgh.2020.10.015
发表时间:2021
期刊:Cellular and molecular gastroenterology and hepatology
影响因子:7.2
作者:Cai Q;Shi P;Yuan Y;Peng J;Ou X;Zhou W;Li J;Su T;Lin L;Cai S;He Y;Xu J
通讯作者:Xu J
肠道微生物调控肝内免疫微环境参与肝脏疾病的机制研究
- 批准号:82220108013
- 项目类别:国际(地区)合作与交流项目
- 资助金额:250万元
- 批准年份:2022
- 负责人:何裕隆
- 依托单位:
强粘附性Mn2+水凝胶TACE栓塞剂对肝癌基于STING介导的免疫干预机制研究
- 批准号:--
- 项目类别:联合基金项目
- 资助金额:260万元
- 批准年份:2020
- 负责人:何裕隆
- 依托单位:
癌周LEC表达CXCL1促进胃癌淋巴道转移的分子机制
- 批准号:81272637
- 项目类别:面上项目
- 资助金额:76.0万元
- 批准年份:2012
- 负责人:何裕隆
- 依托单位:
家族性胃癌遗传易感基因的研究
- 批准号:30571832
- 项目类别:面上项目
- 资助金额:25.0万元
- 批准年份:2005
- 负责人:何裕隆
- 依托单位:
国内基金
海外基金















{{item.name}}会员


